InvestorsHub Logo
Followers 39
Posts 7306
Boards Moderated 0
Alias Born 10/17/2013

Re: None

Wednesday, 10/25/2023 8:50:39 AM

Wednesday, October 25, 2023 8:50:39 AM

Post# of 2339965
ReShape Lifesciences, Inc.
RSLS: soon FDA approval

Total Cash (mrq) 4.57M
Total Cash Per Share (mrq) 1.32
Short % of Shares Outstanding (Oct 12, 2023) 18.00%

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.